Showing codes C9036 (Injection, patisiran, 0.1 mg) — C9066 (Injection, sacituzumab govitecan-hziy, 2.5 mg)

C9036 - Injection, patisiran
Long description: Injection, patisiran, 0.1 mg
Code added date: 20190101.
Code effective date: 20191001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9037 - Injection, risperidone
Long description: Injection, risperidone (perseris), 0.5 mg
Code added date: 20190101.
Code effective date: 20191001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9038 - Inj mogamulizumab-kpkc
Long description: Injection, mogamulizumab-kpkc, 1 mg
Code added date: 20190101.
Code effective date: 20191001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9039 - Injection, plazomicin
Long description: Injection, plazomicin, 5 mg
Code added date: 20190101.
Code effective date: 20191001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9040 - Injection, fremanezumab-vfrm
Long description: Injection, fremanezumab-vfrm, 1mg
Code added date: 20190401.
Code effective date: 20191001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9041 - Inj, coagulation factor xa
Long description: Injection, coagulation factor xa (recombinant), inactivated (andexxa), 10 mg
Code added date: 20190401.
Code effective date: 20200701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9042 - Inj., belrapzo 1 mg
Long description: Injection, bendamustine hcl (belrapzo), 1 mg
Code added date: 20190401.
Code effective date: 20190701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9043 - Injection, levoleucovorin
Long description: Injection, levoleucovorin, 1 mg
Code added date: 20190401.
Code effective date: 20200101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9044 - Injection, cemiplimab-rwlc
Long description: Injection, cemiplimab-rwlc, 1 mg
Code added date: 20190401.
Code effective date: 20191001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9045 - Moxetumomab pasudotox-tdfk
Long description: Injection, moxetumomab pasudotox-tdfk, 0.01 mg
Code added date: 20190401.
Code effective date: 20191001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9046 - Cocaine hcl nasal (goprelto)
Long description: Cocaine hydrochloride nasal solution (goprelto), 1 mg
Code added date: 20190401.
Code effective date: 20230101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9047 - Injection, caplacizumab-yhdp
Long description: Injection, caplacizumab-yhdp, 1 mg
Code added date: 20190701.
Code effective date: 20190701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9048 - Dexamethasone ophth insert
Long description: Dexamethasone, lacrimal ophthalmic insert, 0.1 mg
Code added date: 20190701.
Code effective date: 20191001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9049 - Injection, tagraxofusp-erzs
Long description: Injection, tagraxofusp-erzs, 10 mcg
Code added date: 20190701.
Code effective date: 20191001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9050 - Injection, emapalumab-lzsg
Long description: Injection, emapalumab-lzsg, 1 mg
Code added date: 20190701.
Code effective date: 20191001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9051 - Injection, omadacycline
Long description: Injection, omadacycline, 1 mg
Code added date: 20190701.
Code effective date: 20191001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9052 - Injection, ravulizumab-cwv
Long description: Injection, ravulizumab-cwvz, 10 mg
Code added date: 20190701.
Code effective date: 20191001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9053 - Inj, crizanlizumab-tmca
Long description: Injection, crizanlizumab-tmca, 1 mg
Code added date: 20200401.
Code effective date: 20200701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9054 - Injection, lefamulin
Long description: Injection, lefamulin (xenleta), 1 mg
Code added date: 20200101.
Code effective date: 20200701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9055 - Inj, brexanolone
Long description: Injection, brexanolone, 1mg
Code added date: 20200101.
Code effective date: 20201001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9056 - Injection, givosiran
Long description: Injection, givosiran, 0.5 mg
Code added date: 20200401.
Code effective date: 20200701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9057 - Inj cetirizine hydrochloride
Long description: Injection, cetirizine hydrochloride, 1 mg
Code added date: 20200401.
Code effective date: 20200701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9058 - Injection,pegfilgrastim-bmez
Long description: Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo) 0.5 mg
Code added date: 20191115.
Code effective date: 20200701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9059 - Injection, meloxicam
Long description: Injection, meloxicam, 1 mg
Code added date: 20200701.
Code effective date: 20201001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9060 - Fluoroestradiol f18
Long description: Fluoroestradiol f18, diagnostic, 1 mci
Code added date: 20201001.
Code effective date: 20210101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9061 - Injection, teprotumumab-trbw
Long description: Injection, teprotumumab-trbw, 10 mg
Code added date: 20200701.
Code effective date: 20201001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9062 - Daratumumab hyaluronidase
Long description: Injection, daratumumab 10 mg and hyaluronidase-fihj
Code added date: 20201001.
Code effective date: 20210101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9063 - Injection, eptinezumab-jjmr
Long description: Injection, eptinezumab-jjmr, 1 mg
Code added date: 20200701.
Code effective date: 20201001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9064 - Mitomycin pyelocalyceal inst
Long description: Mitomycin pyelocalyceal instillation, 1 mg
Code added date: 20201001.
Code effective date: 20210101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9065 - Romidepsin non-lyophilized
Long description: Injection, romidepsin, non-lyophilized (e.g. liquid), 1mg
Code added date: 20201001.
Code effective date: 20211001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9066 - Sacituzumab govitecan-hziy
Long description: Injection, sacituzumab govitecan-hziy, 2.5 mg
Code added date: 20201001.
Code effective date: 20210101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF